3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
5
Hepatoblastoma
3
Drug-Related Side Effects and Adverse Reactions
3
Central Nervous System Neoplasms
3
Ototoxicity
2
Oligodendroglioma
2
Neoplasms, Germ Cell and Embryonal
2
Medulloblastoma
2
Glioma
2
Gastrointestinal Neoplasms
2
Astrocytoma
2
Thrombocytopenia
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Seminoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Optic Nerve Glioma
1
Neuroectodermal Tumors, Primitive
1
Neoplasms
1
Mouth Neoplasms
1
Mesothelioma
1
Lymphoma
1
Liver Neoplasms
1
Liposarcoma
1
Interventions
Vincristine
4
Etoposide
4
Doxorubicin
4
Cyclophosphamide
4
Thiotepa
3
Temozolomide
3
Ifosfamide
3
Filgrastim
3
Cisplatin
3
fludarabine phosphate
2
Radiotherapy
2
Melphalan
2
Irinotecan
2
Hyperthermic Intraperitoneal Chemotherapy
2
Granulocyte Colony-Stimulating Factor
2
Cytoreduction Surgical Procedures
2
Brachytherapy
2
thymoglobulin
1
temsirolimus
1
sodium thiosulfate
1
prexasertib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
pazopanib
1
pasireotide
1
fludarabine
1
Zoledronic Acid
1
X-Rays
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Desmoplastic Small Round Cell Tumor
×
sodium thiosulfate
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled